1-5 of 5
Patricia K. Donahoe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1779: Anti-Müllerian hormone type II receptor (AMHRII), a cancer target for GM103, a novel antibody-drug conjugate (ADC)

Olivier Dubreuil, Jean-Marc M. Barret, Raghav Mohan, Martine Pugnière, David Pepin, Delphine Desigaud, William McDowell, Anaïs Manin, Nicolas Camper, André Nicolas, Patricia K. Donahoe, Jean-François F. Prost
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1779.
https://doi.org/10.1158/1538-7445.AM2018-1779
Published: 01 July 2018
View article titled, Abstract 1779: Anti-Müllerian hormone type II receptor (AMHRII), a cancer target for GM103, a novel antibody-drug conjugate (ADC)
Journal Articles

Mullerian-Inhibiting Substance Induces Gro-β Expression in Breast Cancer Cells through a Nuclear Factor-κB–Dependent and Smad1-Dependent Mechanism

Vandana Gupta, Giminna Yeo, Hirofumi Kawakubo, Vivek Rangnekar, Preethi Ramaswamy, Tetsu Hayashida, David T. MacLaughlin, Patricia K. Donahoe, Shyamala Maheswaran
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2747–2756.
https://doi.org/10.1158/0008-5472.CAN-06-2312
Published: 15 March 2007
View article titled, Mullerian-Inhibiting Substance Induces Gro-β Expression in Breast Cancer Cells through a Nuclear Factor-κB–Dependent and Smad1-Dependent Mechanism
Open the PDF for Mullerian-Inhibiting Substance Induces Gro-β Expression in Breast Cancer Cells through a Nuclear Factor-κB–Dependent and Smad1-Dependent Mechanism in another window
Journal Articles

Recombinant Human Mullerian Inhibiting Substance Inhibits Human Ocular Melanoma Cell Lines in Vitro and in Vivo

Robert L. Parry, Taiwai Chin, James Epstein, Peter L. Hudson, David M. Powell, Patricia K. Donahoe
Journal: Cancer Research
Cancer Res (1992) 52 (5): 1182–1186.
Published: 01 March 1992
View article titled, Recombinant Human Mullerian Inhibiting Substance Inhibits Human Ocular Melanoma Cell Lines <em>in Vitro</em> and <em>in Vivo</em>
Open the PDF for Recombinant Human Mullerian Inhibiting Substance Inhibits Human Ocular Melanoma Cell Lines <em>in Vitro</em> and <em>in Vivo</em> in another window
Journal Articles

Human Müllerian Inhibiting Substance Inhibits Tumor Growth in Vitro and in Vivo

Taiwai Chin, Robert L. Parry, Patricia K. Donahoe
Journal: Cancer Research
Cancer Res (1991) 51 (8): 2101–2106.
Published: 01 April 1991
View article titled, Human Müllerian Inhibiting Substance Inhibits Tumor Growth <em>in Vitro</em> and <em>in Vivo</em>
Open the PDF for Human Müllerian Inhibiting Substance Inhibits Tumor Growth <em>in Vitro</em> and <em>in Vivo</em> in another window
Journal Articles

Minimal Antiproliferative Effect of Recombinant Mullerian Inhibiting Substance on Gynecological Tumor Cell Lines and Tumor Explants

John W. Wallen, Richard L. Cate, David M. Kiefer, Mark W. Riemen, Douglas Martinez, Robert M. Hoffman, Patricia K. Donahoe, Daniel D. Von Hoff, Blake Pepinsky, Allen Oliff
Journal: Cancer Research
Cancer Res (1989) 49 (8): 2005–2011.
Published: 01 April 1989
View article titled, Minimal Antiproliferative Effect of Recombinant Mullerian Inhibiting Substance on Gynecological Tumor Cell Lines and Tumor Explants
Open the PDF for Minimal Antiproliferative Effect of Recombinant Mullerian Inhibiting Substance on Gynecological Tumor Cell Lines and Tumor Explants in another window